Alcohol, Drugs, and Impaired Driving addresses many theoretical and practical issues related to the role played by alcohol and other psychoactive drugs on driving performance, road-traffic safety, and public health. Several key forensic issues are involved in the enforcement of laws regulating driving under the influence of alcohol and/or other drugs, including analytical toxicology, pharmacology of drug action, as well as the relationships between dose taken, concentration levels in the body, and impairment of performance and behavior. Our knowledge of drunken driving is much more comprehensive than drugged driving, so a large part of this book is devoted to alcohol impairment, as well as impairment caused by use of drugs other than alcohol. For convenience, the book is divided into four main sections. The first section gives some historical background about measuring alcohol in blood and breath as evidence for the prosecution of traffic offenders. The important role of the Breathalyzer instrument in traffic-law enforcement, especially in Australia, Canada, and the USA is presented along with a biographical sketch of its inventor (Professor Robert F. Borkenstein of Indiana University) with focus on the man, his work and his impact. The second section discusses several issues related to forensic blood and breath-alcohol alcohol analysis as evidence for prosecution of traffic offenders. This includes how the results should be interpreted in relation to impairment and an evaluation of common defense challenges. Because most countries have adopted concentration per se laws, the main thrust of the prosecution case is the suspect’s measured blood- or breath-alcohol concentration. This legal framework necessitates that the analytical methods used are "fit for purpose" and are subjected to rigorous quality assurance procedures. The third section gives a broad overview of the current state of knowledge about driving under the influence of non-alcohol drugs in various countries. This includes adoption of zero-tolerance laws, concentration per se statutes, and clinical evidence of driver impairment based on field sobriety tests and drug recognition expert evidence. The fourth section deals with epidemiology, enforcement, and countermeasures aimed at reducing the threat of drunken and drugged driving. All articles have appeared previously in the international journal Forensic Science Review, but all are completely updated with current data, references, and the latest research on developments since the articles were published. This book contains a convenient collection of the best articles covering recommendations for blood and breath testing methods, public policy relating to such methods, and forensic and legal implications of the enforcement of measures to counter driving under the influence.

This is a 12-session, 24-hour education program for impaired driving offenders who have at least minimal indicators of past problems associated with AOD use or misuse and whose arrest BAC was at the impaired driving level. Level II Education helps clients to understand how problem behaviors are learned and how those behaviors are strengthened. They develop a good understanding of their involvement in impaired driving and how their state laws apply to that involvement. Clients learn how their own AOD use fits clinically identified patterns and cycles of AOD use and misuse. They develop strategies and skills to prevent future problems of use and misuse and involvement in DWI behavior: relapse and recidivism prevention.

This is a three-level education and treatment program for persons convicted of driving while impaired (DWI). Clients learn that change in behavior is made by changing their thoughts, attitudes and beliefs. The books presents a comprehensive overview of cognitive behavioral treatment for impaired driving offenders; a thorough review theory and practice related to client evaluation; legal and cultural considerations; as well as operational procedures for assessing and matching DWI offenders to appropriate levels of education and treatment services. Guidelines are provided for developing individualized treatment plans, and implementing appropriate education and treatment curriculum protocol whereby clients relate and apply the lesson and session material to their own unique circumstances and situations.

Alcohol use by young people is extremely dangerous - both to themselves and society at large. Underage alcohol use is associated with traffic fatalities, violence, unsafe sex, suicide, educational failure, and other problem behaviors that diminish the prospects of future success, as well as health risks â€" and the earlier teens start drinking, the greater the danger. Despite these serious concerns, the media continues to make drinking look attractive to youth, and it remains possible and even easy for teenagers to get access to alcohol. Why is this dangerous behavior so pervasive? What can be done to prevent it? What will work and who is responsible for making sure it happens? Reducing Underage Drinking addresses these questions and proposes a new way to combat underage alcohol use. It explores the ways in which may different individuals and groups contribute to the problem and how they can be enlisted to prevent it. Reducing Underage Drinking will serve as both a game plan and a call to arms for anyone with an investment in youth health and safety.

This is a 12-session, 24-hour education program for impaired driving offenders who have at least minimal indicators of past problems associated with AOD use or misuse and whose arrest BAC was at the impaired driving level. Level II Education helps clients to understand how problem behaviors are learned and how those behaviors are strengthened. They develop a good understanding of their involvement in impaired driving and how their state laws apply to that involvement. Clients learn how their own AOD use fits clinically identified patterns and cycles of AOD use and misuse. They develop strategies and skills to prevent future problems of use and misuse and involvement in DWI behavior: relapse and recidivism prevention.

Driving With Care: Alcohol, Other Drugs, and Driving Safety Education-Strategies for Responsible Living: The Participant′s Workbook, Level II Education, 2e is a 12-session, 24-hour DWI education program for first time offenders who indicate minimal if any problems, other than impaired driving, associated with AOD use, who have no prior offenses, no prior diagnosis of Substance Abuse or Substance Dependence, and no other problems related to AOD use or misuse. The key outcomes for this protocol are to prevent recidivism into DWI behavior and to prevent future AOD related problems.

This new edition follows its predecessors by canvassing all of the recent appellate decisions that have changed the law in this area. The significant changes resulting from the 2008 Bill C-2 amendments to the Criminal Code are also explained along with the cases that have considered those new provisions."--Pub. desc.

Julien’s Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. The thoroughly updated 14th edition features: New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdose. New research on the use of marijuana to treat Alzheimers, PTSD, and Epilepsy. New coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicity. New research on Cannabidiol (CBD) and its therapeutic uses New research of the efficacy of antipsychotics to treat dementia, Parkinson’s, bipolar, OCD, PTSD, New research on hallucinogenics for the treatment of various disorders including MDMA for the treatment of PTSD, Psilocybin for treatment of depression and end-of-life anxiety, and Ayahuasca to treat psychiatric disorders The use of genetic testing to predict effectiveness of antidepressant treatment New research on the use of ketamine for the treatment of depression

Alcohol, Drugs, Genes and the Clinical Laboratory provides an overview and quick reference to genetic relationships and clinical laboratory information related to the serious public health issue of alcohol and drug abuse. Written in a clear and concise manner, this book discusses the necessary information for health and safety professionals working in public health to learn about complex issues quickly to better help their patients, employees, and others affected by alcohol and drug abuse. Alcohol, Drugs, Genes and the Clinical Laboratory covers the important aspects of drugs and alcohol abuse including genetic aspects along with laboratory methods for analysis of alcohol and abused drugs with emphasis on false positive test results. The book is helpful to healthcare professionals, such as pathologists who oversee alcohol and drug testing, emergency room physicians, family practice physicians who are first healthcare professionals who identify patients susceptible to drug and alcohol abuse, and psychiatrists involved with drug and alcohol rehabilitation programs. It will also be useful to safety professionals who have to assess individuals for workplace responsibilities, ranging from police and recruitment to occupational safety and occupational medicine and public health officials. - Features accessible language for healthcare and safety professionals who are not experts in laboratory procedures - Provides examples from clinical and everyday situations - Explains how to interpret laboratory results and the latest genetic factors regarding drug and alcohol abuse